Vedan­ta Bio­sciences taps Big Phar­ma vet Jef­frey Sil­ber as CMO; Robert Doe­bele leaves be­hind teach­ing post at Col­orado to fo­cus on CSO job at Rain Ther­a­peu­tics

→ A Big Phar­ma vet has joined Cam­bridge, MA up­start Vedan­ta Bio­sciences to help de­vel­op and ex­pand on its mi­cro­bio­me-de­rived bac­te­ria port­fo­lio.

Jef­frey Sil­ber signed on as CMO of Vedan­ta af­ter 4 years at EMD Serono as their SVP, glob­al clin­i­cal de­vel­op­ment. Sil­ber worked his way through the ranks at Mer­ck in the late 1990s, even­tu­al­ly be­com­ing their VP and ther­a­peu­tic area head, vac­cine clin­i­cal re­search. And af­ter 16 years at the phar­ma gi­ant, Sil­ber moved on to Ab­b­Vie to be their VP, strate­gic port­fo­lio de­vel­op­ment.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.